Vogenx, Inc. 是一家临床阶段药物开发公司,开发针对代谢类疾病的疗法,包括减重后低血糖(PBH)和胃轻瘫。公司总部位于北卡罗来纳州罗利。
财务指标
营业收入
2026-09-30
$0
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
营业支出
2026-09-30
$178.27万
2026-06-30
$35.53万
2026-03-31
$46.31万
2025-12-31
$45.37万
净利润
2026-09-30
-$490.76万
2026-06-30
-$38.44万
2026-03-31
-$47.54万
2025-12-31
-$50.97万
净利润率
2026-09-30
--
2026-06-30
--
2026-03-31
--
2025-12-31
--
每股收益
2026-09-30
$-0.14
2026-06-30
$-0.07
2026-03-31
--
2025-12-31
--
息税折旧摊销前利润
2026-09-30
-$178.27万
2026-06-30
-$35.53万
2026-03-31
-$46.31万
2025-12-31
-$45.37万
有效税率
2026-09-30
--
2026-06-30
--
2026-03-31
--
2025-12-31
--
项目
2026-09-30
2026-06-30
2026-03-31
2025-12-31
营业收入
$0
$0
$0
$0
营业支出
$178.27万
$35.53万
$46.31万
$45.37万
净利润
-$490.76万
-$38.44万
-$47.54万
-$50.97万
净利润率
--
--
--
--
每股收益
$-0.14
$-0.07
--
--
息税折旧摊销前利润
-$178.27万
-$35.53万
-$46.31万
-$45.37万
有效税率
--
--
--
--
常见问题
VOGX is a publicly traded security that tracks a portfolio of companies rather than representing a single operating business. Its value reflects the combined market performance of the underlying holdings, which may include equities from a specific sector, region, or investment theme. Investors can research its objectives, holdings, and structure through the fund's official documents, such as the prospectus and fact sheet, which outline its strategy and potential risks.
VOGX can be influenced by broad market sentiment, interest rate changes, economic data, and geopolitical events. Because it holds a basket of securities, the performance of its underlying components and their respective sectors also plays a significant role. Additionally, fund-specific factors such as expense ratio, tracking difference, liquidity, and investor flows can affect its market price. Monitoring these elements helps investors understand what may drive VOGX's movement.
The most current VOGX price is available on its stock detail page, which displays real-time or delayed quotes along with trading volume and daily price changes. For historical closing prices and intraday charts, investors can also use brokerage platforms, financial websites, or the fund sponsor's official site. Always rely on the latest displayed data rather than outdated figures when evaluating VOGX.
Valuation for VOGX typically involves examining metrics such as the price-to-earnings ratio, price-to-book ratio, and distribution yield of its underlying holdings. Investors may also compare these metrics against relevant benchmarks or peer funds to gauge relative value. Since VOGX is an ETF, its net asset value (NAV) and market price premium or discount are key considerations. Reviewing the fund's methodology and portfolio composition provides context for these valuation measures.
VOGX carries market risk, meaning its value can decline due to adverse movements in the underlying securities. Sector concentration, if applicable, may amplify volatility, while interest rate changes can affect rate-sensitive holdings. Liquidity risk could impact trading, especially during stressed markets, and tracking error may cause returns to deviate from the index. Investors should review the fund's prospectus for a full list of risks specific to its strategy.
Key metrics for VOGX include expense ratio, which reflects annual operating costs, and tracking difference, which measures how closely the fund follows its index. Distribution yield indicates income potential, while assets under management and average daily volume help assess liquidity. The price-to-earnings and price-to-book ratios of the portfolio offer valuation insight. Reviewing these data points alongside the fund's objective supports a more informed analysis.